Trials / Unknown
UnknownNCT02256579
Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients
Vietnam-Japan Cooperative Research on Prognosis of HIV-1-infection -Clinical Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction Caused by Use of Tenofovir in Vietnamese HIV-Infected Patients-
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,800 (estimated)
- Sponsor
- National Center for Global Health and Medicine, Japan · Other Government
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.
Detailed description
An observational study to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.
Conditions
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-11-01
- Completion
- 2017-03-01
- First posted
- 2014-10-03
- Last updated
- 2014-10-03
Source: ClinicalTrials.gov record NCT02256579. Inclusion in this directory is not an endorsement.